MITCHELL DEAN J
SEC CIK 1199297 · EDGAR
BoughtSold
Most active insiders at TBPH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Samaha Eli | 10% | — | $5.91M |
| 2 | BROSHY ERAN | Dir | — | $2.47M |
| 3 | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | — | $1.46M |
| 4 | Miller Aine | SVP, DEV, HEAD OF IRE OFFICE | — | — |
| 5 | Grimaud Brett A. | SVP, GEN COUNSEL AND Sec | — | — |
| 6 | Sawaf Aziz | SVP, CFO | — | — |
| 7 | GRAY SUSANNAH | Dir | — | — |
| 8 | O'Connor Donal | Dir | — | — |
| 9 | Smaldone Alsup Laurie | Dir | — | — |
| 10 | Winningham Rick E | CEO, Dir | — | — |
| 12 | MITCHELL DEAN J | Dir | — | — |
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-09-24 20:32 | 2026-09-23 | TBPH | Theravance Biopharma, Inc. | MITCHELL DEAN J | Dir | D - Sale to Iss | — | -97.2K | 0 | -100% | — |
| D | 2026-06-16 21:37 | 2026-06-12 | TBPH | Theravance Biopharma, Inc. | MITCHELL DEAN J | Dir | A - Grant | $0.00 | +6,009 | 97.2K | +7% | $0 |
| D | 2026-06-12 17:23 | 2026-06-10 | PRAX | Praxis Precision Medicines, Inc. | MITCHELL DEAN J | Dir | A - Grant | $0.00 | +1,371 | 18.6K | +8% | $0 |
| DM | 2025-09-25 | 2025-09-24 | PRAX | Praxis Precision Medicines, Inc. | MITCHELL DEAN J | Dir | M - OptEx | $39.51 | +12.3K | 6,932 | New | +$484.0K |
| D | 2025-05-21 | 2025-05-19 | TBPH | Theravance Biopharma, Inc. | MITCHELL DEAN J | Dir | A - Grant | $0.00 | +10.6K | 91.2K | +13% | $0 |
| D | 2024-05-10 | 2024-05-08 | TBPH | Theravance Biopharma, Inc. | MITCHELL DEAN J | Dir | A - Grant | $0.00 | +10.5K | 80.6K | +15% | $0 |
| D | 2024-03-18 | 2024-03-14 | PGEN | PRECIGEN, INC. | MITCHELL DEAN J | Dir | A - Grant | $1.43 | +39.5K | 503.2K | +9% | +$56.5K |
| D | 2024-03-12 | 2024-03-09 | PGEN | PRECIGEN, INC. | MITCHELL DEAN J | Dir | M - OptEx | — | +106.8K | 463.7K | +30% | — |
| 2023-09-25 | 2023-09-22 | PGEN | PRECIGEN, INC. | MITCHELL DEAN J | Dir | P - Purchase | $1.41 | +25.0K | 356.8K | +8% | +$35.2K | |
| D | 2023-05-04 | 2023-05-02 | TBPH | Theravance Biopharma, Inc. | MITCHELL DEAN J | Dir | A - Grant | $0.00 | +9,132 | 70.0K | +15% | $0 |
| 2023-03-27 | 2023-03-24 | PRAX | Praxis Precision Medicines, Inc. | MITCHELL DEAN J | Dir | P - Purchase | $0.84 | +50.0K | 75.0K | +200% | +$42.0K | |
| D | 2023-03-13 | 2023-03-09 | PGEN | PRECIGEN, INC. | MITCHELL DEAN J | Dir | A - Grant | $1.17 | +48.3K | 331.8K | +17% | +$56.5K |
| D | 2023-02-24 | 2023-02-22 | PGEN | PRECIGEN, INC. | MITCHELL DEAN J | Dir | M - OptEx | — | +61.6K | 283.5K | +28% | — |
| 2022-06-09 | 2022-06-08 | PRAX | Praxis Precision Medicines, Inc. | MITCHELL DEAN J | Dir | P - Purchase | $1.81 | +25.0K | 25.0K | New | +$45.2K | |
| D | 2022-04-28 | 2022-04-26 | TBPH | Theravance Biopharma, Inc. | MITCHELL DEAN J | Dir | A - Grant | $0.00 | +9,852 | 60.9K | +19% | $0 |
| D | 2022-03-29 | 2022-03-25 | PGEN | PRECIGEN, INC. | MITCHELL DEAN J | Dir | M - OptEx | — | +16.2K | 222.0K | +8% | — |
| D | 2022-02-24 | 2022-02-22 | PGEN | PRECIGEN, INC. | MITCHELL DEAN J | Dir | A - Grant | $2.03 | +27.8K | 205.8K | +16% | +$56.5K |
Purchase Sale Sale after option exercise All abbreviations